4547 Kissei Pharmaceutical
- 3505
- -5-0.14%
Kissei Pharmaceutical News
Kissei Pharmaceutical: Consolidated financial results for the three months ending on June 30, 2024 [Japanese standards]
Kissei Pharmaceutical: Supplementary explanatory materials related to the financial statements for the three-month period ending on June 30, 2024.
Kissei Pharmaceutical: Announcements of individual stocks: Notice of signing a technology transfer contract with JW Pharma Co., Ltd. (South Korea) for Linzagolix.
Kissei Pharmaceutical: Licensing agreement for GnRH antagonist Linzagolix with South Korean pharmaceutical company JW Pharmaceuticals.
Kissei Pharmaceutical: Independent Officer Notification Form
Kissei Pharmaceutical: Financial briefings for the fiscal year ended 2024/3/31
Kissei Pharmaceutical: Consolidated financial results for the fiscal year ended 2024/3/31 [Japanese GAAP]
Kissei Pharmaceutical: Supplementary explanatory materials on financial results for the fiscal year ended 2024/3/31
Kissei Pharmaceutical: 2024 financial results overview
Kissei Pharmaceutical: Notice Concerning Status of Acquisition and Completion of the Company’s Own Shares
Kissei Pharmaceutical Industries: Notice Concerning Status of Share Repurchase
Kissei Pharmaceutical: Notice Concerning Status of Acquisition of the Company’s Own Shares
Kissei Pharmaceutical: Summary of Financial Results for the third quarter 2024
Kissei Pharmaceutical: Consolidated Financial Results for the Nine Months Ended December 31, 2023 [Japanese GAAP]
Kissei Pharmaceutical: Supplementary Explanatory Materials on Financial Results for the Nine Months Ended December 31, 2023
Kissei Pharmaceutical: Notice Concerning Status of Acquisition of the Company’s Own Shares
Kissei Pharmaceutical: KORSUVA IV Injection Syringe for Dialysis to Launch in Japan for Treatment of Pruritus in Patients Undergoing Hemodialysis
Kissei Pharmaceutical: Notice of new release of intravenous dialysis pruritus reliever “Corsva intravenous dialysis syringe 17.5 μg, same 25.0 μg, same 35.0 μg”
Kissei Pharmaceutical: Notice Concerning Status of Acquisition of the Company’s Own Shares
Kissei Pharmaceutical: Announcement concerning the Results of the Acquisition of Treasury Shares through ToSTNeT-3
Analysis
Price Target
No Data
